Evidence map›Paper›PMID 40611921›Full record

ReviewFrontiers in surgery2025

Risk factors for urosepsis following ureteroscopic lithotripsy: a systematic review and meta-analysis.

Lifei Dai, Junlian Xiang, Xiaoli Liu, Xiaoyan Wen, Lin Tan, Jiali Zhang

Abstract readReview
In one paragraph

Review in Frontiers in surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Observational
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Lifei DaiSchool of Basic Medical Sciences & School of Nursing, Chengdu University, Chengdu, China.
Junlian XiangDepartment of Urology, Deyang People's Hospital, Deyang, China.
Xiaoli LiuDepartment of Proctology, Deyang People's Hospital, Deyang, China.
Xiaoyan WenDepartment of Urology, The Affiliated Hospital of Chengdu University, Chengdu, China.
Lin TanDepartment of Urology, Deyang People's Hospital, Deyang, China.
Jiali ZhangSchool of Basic Medical Sciences & School of Nursing, Chengdu University, Chengdu, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Ureteroscopic lithotripsy (URSL) is the preferred treatment for urinary tract stones, with urosepsis being its most severe postoperative complication. Although previous studies have investigated risk factors for urosepsis after URSL, significant variations exist in reported risk factors and their associated odds ratios ( Methods: Case-control and cohort studies on factors influencing urosepsis after URSL were systematically retrieved from major public medical databases, including PubMed, Web of Science, Embase, Cochrane Library, China National Knowledge Infrastructure (CNKI), Wanfang Data, and Chinese Science and Technology Journal Database, up to January 31, 2025. Two researchers independently conducted literature screening, data extraction, quality assessment, and meta-analysis using Stata versions 15.1 and 18.0. Results: A total of 26 studies were included in this analysis, comprising 12,394 patients, of whom 861 patients developed urosepsis. The influencing factors for urosepsis included stone size[OR = 3.10, 95% CI (1.20,8.00), Conclusion: Urosepsis following URSL is associated with a high mortality rate and significantly threatens patient safety and quality of life. Early identification of the factors influencing urosepsis is crucial to reduce its incidence and improve patient outcomes. Systematic Review Registration: PROSPERO CRD42025641787.

Indexed as

disease prevention and controllithotripsymeta-analysisrisk factorssepsis

Identifiers

PMID40611921
PMCPMC12222153

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.